What You Should Know:
– Cedar Gate Technologies (Cedar Gate), a leader in value-based care technology, announced today the potential for significant healthcare cost savings through early identification of at-risk patients.
– An analysis…
Continue Reading
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound…
Continue Reading
By Shania Kennedy
April 22, 2024 – Researchers from the University of Virginia (UVA) have developed a machine learning tool designed to assess and predict adverse outcome risks for patients with advanced heart failure with reduced…
Continue Reading
As clinicians know, addressing the needs of patients living with chronic conditions, such as heart failure, Type 2 diabetes or hypertension, places a high level of strain on primary care providers and health systems….
Continue Reading
Cardiac digital twins provide a physics and physiology informed framework to deliver personalized medicine. However, high-fidelity multi-scale cardiac models remain a barrier to adoption due to their extensive computational costs. Artificial Intelligence-based methods can…
Continue Reading
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure.
About 6.2 million Americans battle heart failure,…
Continue Reading
Hospital patients with conditions like pneumonia, dehydration and heart failure have been shown to experience shorter recovery times with fewer complications when they receive more cost-effective healthcare at home – and many health systems have…
Continue Reading
Eko Health celebrates a significant milestone with FDA 510(k) clearance for its AI-enabled cardiac tool, the Eko Low Ejection Fraction Tool (ELEFT). This groundbreaking innovation streamlines cardiac care by swiftly identifying low ejection fraction,…
Continue Reading
Digital cardiac and lung disease health startup Eko Health announced it received FDA 510(k) clearance for its AI-enabled cardiac tool that helps with the early detection of low ejection fraction, a key indicator of…
Continue Reading
What You Should Know:
– Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.
– Built in collaboration with Mayo Clinic, the AI allows…
Continue Reading
